Advertisement

The Neuronal Ceroid Lipofuscinoses-Linked Loss of Function CLN5 and CLN8 Variants Disrupt Normal Lysosomal Function

  • Shaho Parvin
  • Maryam Rezazadeh
  • Hassan Hosseinzadeh
  • Mohsen Moradi
  • Shadi Shiva
  • Jalal GharesouranEmail author
Original Paper
  • 130 Downloads

Abstract

Neuronal ceroid lipofuscinoses (NCLs) are a group of neurodegenerative disorders caused by mutations in fourteen distinct ceroid lipofuscinoses, neuronal (CLN) genes described with various severe symptoms such as seizures, visual failure, motor decline, and progressive cognitive deterioration. The current research represents novel CLN5 (c.741G > A) and CLN8 (c.565delT) mutations in two different Iranian families with late-infantile NCL (LINCL) and their relatives by using whole-exome sequencing (WES). The first family had a 10-year-old male with consanguineous parents and severe NCL symptoms, including motor clumsiness, telangiectasia, and cerebellar atrophy. The second family with a child who suffered from nystagmus rotation, motor difficulties, and seizure was a 5-year-old male with consanguineous parent. WES of probands 1 and 2 revealed homozygotic mutations in exon 4 of CLN5 (c.741G > A, p.W247X) and deletion in exon 3 (c.565delT, p.F189fs) of CLN8, respectively. Both patients’ parents were heterozygous for these alterations. In concordance with previous studies, our results indicate that pathogenic mutations in CLN genes, especially CLN5 and 8, are a main cause of LINCL; these results also suggest that LINCL is not a regionally or nationally dependent disorder and can occur in any ethnic group despite the fact that some populations may be more at risk. Consequently, CLN gene screening for patients with typical signs of LINCL is recommended.

Keywords

Neuronal ceroid lipofuscinoses Whole-exome sequencing CLN5 CLN8 

Notes

Acknowledgements

The authors deeply acknowledge all the study participants for their cooperation and contribution towards this study.

References

  1. Beesley, C., Guerreiro, R. J., Bras, J. T., Williams, R. E., Taratuto, A. L., Eltze, C., & Mole, S. E. (2017). CLN 8 disease caused by large genomic deletions. Molecular Genetics & Genomic Medicine, 5(1), 85–91.CrossRefGoogle Scholar
  2. Cannelli, N., Cassandrini, D., Bertini, E., Striano, P., Fusco, L., Gaggero, R.,.. . Bruno, C. (2006). Novel mutations in CLN8 in Italian variant late infantile neuronal ceroid lipofuscinosis: Another genetic hit in the Mediterranean. Neurogenetics, 7(2), 111.CrossRefGoogle Scholar
  3. Gao, Z., Xie, H., Jiang, Q., Wu, N., Chen, X., & Chen, Q. (2018). Identification of two novel null variants in CLN8 by targeted next-generation sequencing: First report of a Chinese patient with neuronal ceroid lipofuscinosis due to CLN8 variants. BMC medical genetics, 19(1), 21.CrossRefPubMedCentralGoogle Scholar
  4. Getty, A. L., & Pearce, D. A. (2011). Interactions of the proteins of neuronal ceroid lipofuscinosis: Clues to function. Cellular and molecular life sciences, 68(3), 453–474.CrossRefGoogle Scholar
  5. Haddad, S. E., Khoury, M., Daoud, M., Kantar, R., Harati, H., Mousallem, T.,.. . Boustany, R. M. (2012). CLN 5 and CLN 8 protein association with ceramide synthase: B iochemical and proteomic approaches. Electrophoresis, 33(24), 3798–3809.CrossRefGoogle Scholar
  6. Hall, J. C., Dunlap, J. C., Friedmann, T., Giannelli, F., Wisniewski, K. E., & Zhong, N. (2001). Batten disease: Diagnosis, treatment, and research (Vol. 45). Amsterdam: Elsevier.Google Scholar
  7. Haltia, M. (2003). The neuronal ceroid-lipofuscinoses. Journal of Neuropathology & Experimental Neurology, 62(1), 1–13.CrossRefGoogle Scholar
  8. Herva, R., Tyynelä, J., Hirvasniemi, A., Syrjäkallio-Ylitalo, M., & Haltia, M. (2000). Northern epilepsy: A novel form of neuronal ceroid-lipofuscinosis. Brain Pathology, 10(2), 215–222.CrossRefGoogle Scholar
  9. Holmberg, V., Jalanko, A., Isosomppi, J., Fabritius, A.-L., Peltonen, L., & Kopra, O. (2004). The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain. Neurobiology of Disease, 16(1), 29–40.CrossRefGoogle Scholar
  10. Jalanko, A., & Braulke, T. (2009). Neuronal ceroid lipofuscinoses. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1793(4), 697–709.CrossRefGoogle Scholar
  11. Katata, Y., Uematsu, M., Sato, H., Suzuki, S., Nakayama, T., Kubota, Y.,.. . Kure, S. (2016). Novel missense mutation in CLN8 in late infantile neuronal ceroid lipofuscinosis: The first report of a CLN8 mutation in Japan. Brain and Development, 38(3), 341–345.CrossRefGoogle Scholar
  12. Kollmann, K., Uusi-Rauva, K., Scifo, E., Tyynelä, J., Jalanko, A., & Braulke, T. (2013). Cell biology and function of neuronal ceroid lipofuscinosis-related proteins. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1832(11), 1866–1881.CrossRefGoogle Scholar
  13. Kopra, O., Vesa, J., von Schantz, C., Manninen, T., Minye, H., Fabritius, A.-L.,.. . Jalanko, A. (2004). A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Human Molecular Genetics, 13(23), 2893–2906.CrossRefGoogle Scholar
  14. Kousi, M., Lehesjoki, A. E., & Mole, S. E. (2012). Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Human Mutation, 33(1), 42–63.CrossRefGoogle Scholar
  15. Lonka, L., Kyttälä, A., Ranta, S., Jalanko, A., & Lehesjoki, A.-E. (2000). The neuronal ceroid lipofuscinosis CLN8 membrane protein is a resident of the endoplasmic reticulum. Human Molecular Genetics, 9(11), 1691–1697.CrossRefGoogle Scholar
  16. Lonka, L., Salonen, T., Siintola, E., Kopra, O., Lehesjoki, A. E., & Jalanko, A. (2004). Localization of wild-type and mutant neuronal ceroid lipofuscinosis CLN8 proteins in non-neuronal and neuronal cells. Journal of Neuroscience Research, 76(6), 862–871.CrossRefGoogle Scholar
  17. Mahajnah, M., & Zelnik, N. (2012). Phenotypic heterogeneity in consanguineous patients with a common CLN8 mutation. Pediatric Neurology, 47(4), 303–305.CrossRefGoogle Scholar
  18. Mamo, A., Jules, F., Dumaresq-Doiron, K., Costantino, S., & Lefrancois, S. (2012). The role of ceroid lipofuscinosis neuronal protein 5 (CLN5) in endosomal sorting. Molecular and Cellular Biology, 32(10), 1855–1866.CrossRefPubMedCentralGoogle Scholar
  19. Mancini, C., Nassani, S., Guo, Y., Chen, Y., Giorgio, E., Brussino, A.,.. . Funaro, A. (2015). Adult-onset autosomal recessive ataxia associated with neuronal ceroid lipofuscinosis type 5 gene (CLN5) mutations. Journal of Neurology, 262(1), 173–178.CrossRefGoogle Scholar
  20. Marotta, D., Tinelli, E., & Mole, S. E. (2017). NCLs and ER: A stressful relationship. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(6), 1273–1281.CrossRefGoogle Scholar
  21. Martinez, L. O., Jacquet, S., Esteve, J.-P., Rolland, C., Cabezón, E., Champagne, E.,.. . Tercé, F. (2003). Ectopic β-chain of ATP synthase is an apolipoprotein AI receptor in hepatic HDL endocytosis. Nature, 421(6918), 75.CrossRefGoogle Scholar
  22. Mole, S. E., & Cotman, S. L. (2015). Genetics of the neuronal ceroid lipofuscinoses (Batten disease). Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1852(10), 2237–2241.CrossRefGoogle Scholar
  23. Mole, S. E., Williams, R. E., & Goebel, H. H. (2005). Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics, 6(3), 107–126.CrossRefGoogle Scholar
  24. Ranta, S., Topcu, M., Tegelberg, S., Tan, H., Üstübütün, A., Saatci, I.,.. . Alembik, Y. (2004). Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Human Mutation, 23(4), 300–305.CrossRefGoogle Scholar
  25. Reinhardt, K., Grapp, M., Schlachter, K., Brück, W., Gärtner, J., & Steinfeld, R. (2010). Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis. Clinical Genetics, 77(1), 79–85.CrossRefGoogle Scholar
  26. Schmiedt, M. L., Bessa, C., Heine, C., Ribeiro, M. G., Jalanko, A., & Kyttälä, A. (2010). The neuronal ceroid lipofuscinosis protein CLN5: New insights into cellular maturation, transport, and consequences of mutations. Human Mutation, 31(3), 356–365.CrossRefGoogle Scholar
  27. Schmiedt, M.-L., Blom, T., Blom, T., Kopra, O., Wong, A., von Schantz-Fant, C.,.. . Cooper, J. D. (2012). Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism. Neurobiology of Disease, 46(1), 19–29.CrossRefGoogle Scholar
  28. Schulz, A., Dhar, S., Rylova, S., Dbaibo, G., Alroy, J., Hagel, C.,.. . Boustany, R. M. (2004). Impaired cell adhesion and apoptosis in a novel CLN9 Batten disease variant. Annals of Neurology, 56(3), 342–350.CrossRefGoogle Scholar
  29. Setty, G., Saleem, R., Khan, A., & Hussain, N. (2013). Atypical juvenile neuronal ceroid lipofuscinosis: A report of three cases. Journal of Pediatric Neurosciences, 8(2), 117.CrossRefPubMedCentralGoogle Scholar
  30. Siintola, E., Topcu, M., Aula, N., Lohi, H., Minassian, B. A., Paterson, A. D.,.. . Anttonen, A.-K. (2007). The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter. The American Journal of Human Genetics, 81(1), 136–146.CrossRefGoogle Scholar
  31. Tyynelä, J., Cooper, J. D., Khan, M. N., Shemilt, S. J., & Haltia, M. (2004). Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: Distinct patterns of storage deposition, neurodegeneration and glial activation. Brain Pathology, 14(4), 349–357.CrossRefGoogle Scholar
  32. Uusi-Rauva, K., Blom, T., von Schantz-Fant, C., Blom, T., Jalanko, A., & Kyttälä, A. (2017). Induced pluripotent stem cells derived from a CLN5 patient manifest phenotypic characteristics of neuronal ceroid lipofuscinoses. International Journal of Molecular Sciences, 18(5), 955.CrossRefPubMedCentralGoogle Scholar
  33. Vantaggiato, C., Redaelli, F., Falcone, S., Perrotta, C., Tonelli, A., Bondioni, S.,.. . Bonaglia, M. C. (2009). A novel CLN8 mutation in late-infantile-onset neuronal ceroid lipofuscinosis (LINCL) reveals aspects of CLN8 neurobiological function. Human Mutation, 30(7), 1104–1116.CrossRefGoogle Scholar
  34. Vesa, J., & Peltonen, L. (2002). Mutated genes in juvenile and variant late infantile neuronal ceroid lipofuscinoses encode lysosomal proteins. Current Molecular Medicine, 2(5), 439–444.CrossRefGoogle Scholar
  35. von Schantz, C., Saharinen, J., Kopra, O., Cooper, J. D., Gentile, M., Hovatta, I.,.. . Jalanko, A. (2008). Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases. BMC Genomics, 9(1), 146.CrossRefGoogle Scholar
  36. Warrier, V., Vieira, M., & Mole, S. E. (2013). Genetic basis and phenotypic correlations of the neuronal ceroid lipofusinoses. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1832(11), 1827–1830.CrossRefGoogle Scholar
  37. Williams, R. E., & Mole, S. E. (2012). New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology, 79(2), 183–191.CrossRefGoogle Scholar
  38. Winter, E., & Ponting, C. P. (2002). TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains? Trends in Biochemical Sciences, 27(8), 381–383.CrossRefGoogle Scholar
  39. Xin, W., Mullen, T., Kiely, R., Min, J., Feng, X., Cao, Y.,.. . Mole, S. (2010). CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL. Neurology, 74(7), 565–571.CrossRefGoogle Scholar
  40. Zelnik, N., Mahajna, M., Iancu, T. C., Sharony, R., & Zeigler, M. (2007). A novel mutation of the CLN8 gene: is there a Mediterranean phenotype? Pediatric Neurology, 36(6), 411–413.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Molecular GeneticsRabe Rashidi InstituteTabrizIran
  2. 2.Department of Medical Genetics, Faculty of MedicineTabriz University of Medical SciencesTabrizIran
  3. 3.Division of Medical Genetics, Tabriz Children’s HospitalTabriz University of Medical SciencesTabrizIran
  4. 4.Department of Biology, Faculty of ScienceYazd UniversityYazdIran
  5. 5.Department of Allergy and Clinical Immunology, Pediatric HospitalTabriz University of Medical SciencesTabrizIran
  6. 6.Department of Medical Genetics, Faculty of MedicineTabriz University of Medical SciencesTabrizIran

Personalised recommendations